Insulin aspart, recombinant Subcutaneous and Opcon-A Eye Drops
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Opcon-A Eye Drops and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: naphazoline / pheniramine ophthalmic
Brand name: Naphcon-A, Opcon-A, Visine-A, AK-Con-A, Ocuhist
Synonyms: Opcon-A
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Opdivo
- Insulin aspart, recombinant Subcutaneous-Ophtho-Chloram
- Insulin aspart, recombinant Subcutaneous-Opium
- Insulin aspart, recombinant Subcutaneous-Opium Deodorized
- Insulin aspart, recombinant Subcutaneous-Opium preparation
- Insulin aspart, recombinant Subcutaneous-Opium Tincture
- Opcon-A Eye Drops-Insulin degludec
- Opcon-A Eye Drops-Insulin Degludec (U-100) Prefilled Pens
- Opcon-A Eye Drops-Insulin Degludec (U-100) Vials
- Opcon-A Eye Drops-Insulin Degludec (U-200) Prefilled Pens
- Opcon-A Eye Drops-Insulin degludec and liraglutide
- Opcon-A Eye Drops-Insulin degludec and liraglutide Subcutaneous